Read review Dihexa for Migraine & Chronic Migraine The May 2024 NICE TA973 atogepant (Aquipta, AbbVie) approval, the rimegepant / erenumab / galcanezumab / fremanezumab / eptinezumab CGRP pathway, 2025 chronic-migraine hippocampal atrophy & accelerated brain ageing research, the Tanure BDNF-elevated-in-attack paradox, NICE NG150, and the ~10 million UK migraine population
Is GHK-Cu for human or animal use
They are not magic bullets, so they work best layered onto a foundation of good training, protein, and sleep
The Diluent: This is the liquid you'll use to reconstitute the peptide
During this consultation, we check your vitals and review your health history to tailor the treatment to your specific needs
Whether youre recovering from dehydration, looking to boost your immune system, or seeking an energy refresh, our IV Hydration therapies are designed to help you feel revitalized and rejuvenated